Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

465
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

392
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
392
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

480
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
480
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

385
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
385
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Angina IV: Management01:26

Angina IV: Management

330
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
330

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cesarean Section Rates and Mobile Health's Role in Equitable Access to Prenatal Care.

International journal of environmental research and public health·2026
Same author

Accelerated 3YMD programs: the last decade of growth of the Consortium of Accelerated Medical Pathway Programs (CAMPP).

Medical education online·2024
Same author

Departmental Metrics to Guide Equity, Diversity, and Inclusion for Academic Family Medicine Departments.

Family medicine·2024
Same author

Managing TIA: Early action and essential risk-reduction steps.

The Journal of family practice·2022
Same author

Integrating Simulated Patients in TBL: a Strategy for Success in Medical Education.

Medical science educator·2021
Same author

Caring for patients with co-occurring mental health & substance use disorders.

The Journal of family practice·2019

Related Experiment Video

Updated: Feb 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Recurrent Ischemic Stroke: Strategies for Prevention.

Rupal Oza1, Kristen Rundell1, Miriam Garcellano1

  • 1The Ohio State University Wexner Medical Center, Columbus, OH, USA.

American Family Physician
|November 3, 2017
PubMed
Summary

Recurrent strokes are common, with aspirin recommended for initial prevention. Long-term aspirin and clopidogrel combination therapy is not advised due to bleeding risks.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Recurrent strokes account for nearly 25% of annual strokes in the US.
  • Key risk factors include hypertension, diabetes, hyperlipidemia, sleep apnea, and obesity.
  • Lifestyle changes like smoking cessation and increased physical activity are crucial.

Purpose of the Study:

  • To review current recommendations for antiplatelet therapy in preventing recurrent ischemic strokes.
  • To guide the selection of appropriate antiplatelet agents based on various factors.

Main Methods:

  • Review of clinical guidelines and evidence regarding antiplatelet therapies.
  • Analysis of safety, effectiveness, cost, and patient-specific factors for treatment selection.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

18.0K

Related Experiment Videos

Last Updated: Feb 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

18.0K

Main Results:

  • Aspirin is the recommended initial treatment for preventing recurrent ischemic stroke.
  • Clopidogrel serves as an alternative monotherapy or for aspirin-allergic patients.
  • Long-term dual antiplatelet therapy (aspirin/clopidogrel) is not recommended due to increased bleeding risk; aspirin/dipyridamole is an option but less tolerated.

Conclusions:

  • Individualized selection of antiplatelet therapy is essential for recurrent stroke prevention.
  • Aspirin monotherapy is the primary recommendation, with specific alternatives available.
  • Careful consideration of risks and benefits guides optimal long-term management.